Pre-treatment of the beta3-adrenergic receptor agonist BRL37344 reduces in vivo myocardial ischemia/reperfusion injury by improving AMPK and SIRT1 activity and by suppressing mTOR and p70S6K signaling pathways

Ozek, Dilan Askin; Onat, Elif; Sahin, Kazim; Tuzcu, Mehmet; Bozoglan, Merve Yilmaz; Sahna, Engin.
Braz. J. Pharm. Sci. (Online) ; 59: e23002, 2023. graf
Artículo en Inglés | LILACS-Express | ID: biblio-1520312